Dr. Richard D. Hall
Claim this profileUniversity of Virginia Cancer Center
Area of expertise
Lung Cancer
Richard D. Hall has run 14 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Richard D. Hall has run 10 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Virginia Cancer Center
University Of Virginia Health System
Clinical Trials Richard D. Hall is currently running
Fianlimab + Cemiplimab
for Non-Small Cell Lung Cancer
This trial is testing a new drug combination for patients with advanced lung cancer. It aims to see if using two drugs together is more effective than one alone. The study also looks at side effects, how the drugs are processed in the body, and their impact on quality of life.
Recruiting
0 awards
Phase 2 & 3
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting
2 awards
Phase 3
31 criteria
More about Richard D. Hall
Clinical Trial Related
2 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 8 Active Clinical Trials
Treatments Richard D. Hall has experience with
- Osimertinib
- Carboplatin
- Pembrolizumab
- Atezolizumab
- Cisplatin
- Durvalumab
Breakdown of trials Richard D. Hall has run
Lung Cancer
Non-Small Cell Lung Cancer
Anaplastic Large Cell Lymphoma
ALK Gene Rearrangement
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richard D. Hall specialize in?
Richard D. Hall focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Richard D. Hall currently recruiting for clinical trials?
Yes, Richard D. Hall is currently recruiting for 8 clinical trials in Charlottesville Virginia. If you're interested in participating, you should apply.
Are there any treatments that Richard D. Hall has studied deeply?
Yes, Richard D. Hall has studied treatments such as Osimertinib, Carboplatin, Pembrolizumab.
What is the best way to schedule an appointment with Richard D. Hall?
Apply for one of the trials that Richard D. Hall is conducting.
What is the office address of Richard D. Hall?
The office of Richard D. Hall is located at: University of Virginia Cancer Center, Charlottesville, Virginia 22908 United States. This is the address for their practice at the University of Virginia Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.